Pharmaceuticals

How Canada’s new cannabis regime will impact a range of brands and law firms

With Canada set to legalise recreational cannabis, our latest opinion column looks at why trademark counsel should watch this development closely.

How Canada’s new cannabis regime will impact a range of brands and law firms
10 Jul 2018

Novichok trademark flurry, gift shop seeks IT'S COMING HOME mark and IHOb is no more: news round-up

In our latest round-up, we look at the UK gift shop seeking registered trademark protection for "It's coming home", the new Cornish pasties authentication scheme, Kenya stepping up its anti-counterfeit efforts, and much more.

19 Jun 2018

“We try to take smart risks”: Sandoz International’s business-focused reproach to rights management

How Sandoz International, this year’s WTR Industry Awards Healthcare and Life Sciences Team of the Year, adapts its enforcement strategies to keep one step ahead of infringers.

Latest

View all
8 Oct 2018

General Court confirms likelihood of confusion between GN LABORATORIES and GNC - despite relevant public’s above-average level of attention  

In Ntolas v EUIPO, the EU General Court has confirmed that there was a likelihood of confusion between the mark GN LABORATORIES for goods in Classes 5, 29 and 30, and the earlier mark GNC for goods and services in Classes 5, 29 and 35. Read more

4 Oct 2018

AKANTO v KANTOS - is suggestive character subject to proof?

The EU General Court has confirmed that there was a likelihood of confusion between Novartis AG’s mark AKANTO and Chiesi Farmaceutici SpA’s earlier mark KANTOS for goods in Class 5. Read more

1 Oct 2018

Courts will deal with manufacturers of counterfeit drugs severely, warns Bombay High Court

In Shalina Laboratories Private Limited v Twin Impex, the Bombay High Court has imposed substantial costs on the defendants for copying all the features of the plaintiff’s pharmaceutical products. Read more

27 Sep 2018

Parallel imports: when a name change is a game changer

The Administrative Court of Lazio in Italy has issued an important decision concerning the parallel importation of medicinal products which are placed on the market in the European Union under different trademarks. Read more

News

View all
5 Jun 2018

Bayer retires Monsanto brand, cocky trademark struck down and Nigeria kit attracts counterfeiters: news round-up

In our latest round-up, we look at Bayer deciding to retire the century-old Monsanto brand name, Kenzo prevailing in a trademark suit, Kenya Revenue authority destroying millions worth of fake alcohol, and much more. Read more

18 May 2018

The world’s leading corporate trademark professionals revealed

Released today, Apple, Mars and Procter & Gamble head up the 2018 edition of the WTR 300: The World’s Leading Corporate Trademark Professionals. Now in its second edition, this community-led research project identifies the leading lights of the corporate trademark world. Read more

19 Apr 2018

WTR Industry Awards 2018: the shortlist revealed

The WTR Industry Awards 2018  honour leading trademark teams and individuals across a range of sectors. We reveal the shortlist. Read more

17 Apr 2018

WHOIS access charges, NGOs take aim at watch list plans and INTA applauds ‘Brand India’: news round-up

In our latest round-up, we look at a registry’s plans to charge trademark owners for access to WHOIS data and  the war of words over plans for an IP markets watch list. Read more

Analysis

View all
2 Aug 2018

Court of Appeal provides salutary lesson to mark owners who license their trademark portfolios

The decision of the Court of Appeal of England and Wales in Holland and Barrett v General Nutrition provides valuable guidance for mark owners who license their main brand as well as a number of sub-brands. Read more

1 Aug 2018

Anti-sanction bill keeps intellectual property in safe harbour

A new anti-sanction bill aimed at the prevention and suppression of unlawful and hostile foreign actions is now in force in Russia. Importantly, the bill generally does not concern the IP assets of foreign legal entities. Read more

3 Jul 2018

General Court finds no likelihood of confusion between pharma marks with same suffix; annuls Board of Appeal decision

The EU General Court has annulled a decision of the Board of Appeal of the EUIPO finding that there was a likelihood of confusion between Tillotts' XENASA mark and Ferring’s earlier PENTASA mark in Class 5. Read more

27 Jun 2018

Are services in Classes 42 and 44 similar to goods in Class 5? The General Court decides

The EU General Court has annulled a decision of the Board of Appeal of the EUIPO, finding that there was a likelihood of confusion between the mark EMCURE in Classes 42 and 44 and the earlier mark EMCUR in Class 5. Read more

Research

View all
9 Feb 2018

Healthcare market robust – brands prosper while Chinese filings dominate: exclusive data analysis

In our latest industry data report, we explore the thriving and evolving healthcare industry. Our in-depth analysis reveals the trends driving this evolution, while also analysing key trademark filing statistics in this space. Read more

1 Jan 2018

Big changes in the pharmaceutical sector as leading brands flourish

A deep dive into key data about the pharmaceuticals sector suggests that over-regulation and availability of skills and technology remain key challenges; while the leading brands continue to rise in value, most are still filing in single classes only Read more

24 Nov 2017

Big changes in the pharmaceutical sector as leading brands flourish: exclusive data analysis

In this week’s data report, we turn the spotlight on the sprawling pharmaceutical sector. We look at how the sector is being affected by political pressures, and identify the developments that are driving change. Read more

Insight

View all
13 Mar 2018

Procedures and strategies for pharmaceutical brands: Chile

Two frameworks are applicable to pharmaceutical marks in Chile. The Industrial Property Law and its regulation set out the rules for the registration and use of trademarks; the Sanitary Code and Decree 3/2010 regulate the pharmaceutical product marketing authorisation procedure. Read more

13 Mar 2018

Procedures and strategies for pharmaceutical brands: Canada

Sweeping amendments to the Trademarks Act are expected to be implemented in 2019. The amendments will fundamentally affect the way in which all trademark owners will need to approach their selection, clearance and registration strategies, and the pharmaceutical industry is no exception. Read more

13 Mar 2018

Procedures and strategies for pharmaceutical brands: Brazil

Brazil is a first-to-file jurisdiction, and therefore IP rights are acquired only when an application is filed and registered with the Brazilian Patent and Trademark Office. However, pharmaceutical trademarks fall under two separate and independent statutory regimes. Read more

13 Mar 2018

Procedures and strategies for pharmaceutical brands: France

In order for a pharmaceutical trademark to be registered, no prior authorisation is needed per se. Unlike in other countries, in France the trademark owner is independent from the party exploiting the trademark and need not possess a particular quality. Read more